Drugs / Epigallocatechin gallate (EGCG)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02891538 | Jan 2017 → Jun 2024 | colon carcinoma | The University of Texas Health Science Center at San Antonio | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Epigallocatechin gallate (EGCG) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02891538 ↗ |
| Route | Oral | “take EGCG 450 mg PO twice a day” NCT02891538 ↗ |